Studies show effectiveness of combo treatment for HCV patients with, without cirrhosis The JAMA Network Journals 8m

Related content

• Research output

• Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection

  Research output: Contribution to journal › Article › peer-review

• Daclatasvir in combination with asunaprevir and beclabuvir for hepatitis C virus genotype 1 infection with compensated cirrhosis

  Research output: Contribution to journal › Article › peer-review